Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma
Authors:
Open Access
- 1 January 2015
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (13) , 3970-3977
Abstract
AIM: To investigate transarterial chemoembolization (TACE) with hepatic infusion of oxaliplatin and 5-fluorouracil and Lipiodol chemoembolization in large hepatocellular carcinoma (HCC).Keywords
This publication has 36 references indexed in Scilit:
- Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinomaNuclear Medicine Communications, 2013
- Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Recent Progression and PerspectiveOncology, 2013
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated VersionDigestive Diseases, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Safety and efficacy of partial hepatectomy for huge (≥10 cm) hepatocellular carcinoma: A systematic reviewMedical Science Monitor, 2011
- Loco‐regional treatment of hepatocellular carcinoma†Hepatology, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- OEM-TACE: A New Therapeutic Approach in Unresectable Intrahepatic CholangiocarcinomaCardioVascular and Interventional Radiology, 2009
- Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.2009
- Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.2009